Loading…
Wednesday, June 27 • 4:00pm - 5:15pm
#397: Design and Statistical Considerations for Real World Evidence to Support Regulatory Decision Making

Sign up or log in to save this to your schedule and see who's attending!

Tweet Share
Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-686-L04-P; CME 1.25; IACET 1.25; RN 1.25

Regulators expect drug makers to conduct novel studies to provide treatment effectiveness results that are valid in everyday clinical practice. This session will present opportunities and challenges in pragmatic trials to generate real-world insights.

Learning Objectives

Discuss the usefulness of pragmatic clinical trials to support regulatory decision making and shortening drug approval time; Describe how pragmatic trials offer avenue to obtain real-world data to support comparative effectiveness research; Describe design and statistical considerations for pragmatic trials to produce acceptable, valid, precise, and generalizable results.

Chair

Yeh-Fong Chen, PhD

Speaker

Design and Statistical Considerations in Real-World Evidence
Jennifer Hsiang-Ling Lin, PhD

Pragmatic Clinical Trials: The Future is Now
David Thompson, PhD


Speakers
avatar for Yeh-Fong Chen

Yeh-Fong Chen

Mathematical Statistician, Office of Translational Sciences, CDER, FDA
Dr. Yeh-Fong Chen is the statistical team leader supporting the Division of Gastroenterology and Inborn Errors Products at the Division of Biometrics III at US Food and Drug Association. She joined FDA in 2000 immediately after graduation with a PhD degree in Statistics from the University... Read More →
JH

Jennifer Hsiang-Ling Lin

Associate Director, RWE Design and Analytics, Janssen Pharmaceuticals
Jennifer currently works at Janssen as a research scientist specializing in patient outcomes and treatment effectiveness. Before joining Janssen, she was at Takeda, leading an observational research analytics team in support of company products via use of RWD. She was also the principal... Read More →
avatar for David Thompson

David Thompson

Senior Vice President, Real World and Late Phase Research, Syneos Health
David Thompson, PhD is a health economist with 30+ years of experience in HEOR consulting and real-world research design. He currently holds the position of Senior Vice President for Real-World & Late Phase Research at Syneos Health, where he provides RWE design solutions to study... Read More →

Wednesday June 27, 2018 4:00pm - 5:15pm
Room 256 Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  11: Statistics, Session